Salesforce's stock gets an Anthropic boost - and more highlights from earnings
Salesforce (CRM) reported Q2 2027 revenue of $11.35B, up 11% YoY, beating estimates. Earnings per share of $5.90 included a gain from its investment in AI lab Anthropic. The company also announced a strategic partnership with Anthropic, called Claudeforce. Salesforce shares rose 13% in extended trading. The company raised its full-year revenue guidance to $46.1B-$46.4B, citing strong demand for its AI products.
How this was made
The 30-second read
Why it matters
The earnings beat and guidance raise expectations for accelerated revenue growth, especially in AI‑related offerings.
Market read
Strong earnings and AI partnership provide a fresh catalyst for CRM, likely prompting short‑term buying pressure.
What to watch
Potential competitive pressure from other AI‑enabled platforms and macro‑economic headwinds could temper upside.
Background
Salesforce's Q2 FY2027 earnings beat expectations, driven by AI product adoption and a strategic partnership with Anthropic.
Ticker impact
Salesforce reported Q2 FY2027 revenue of $11.35B, beat estimates, and its shares jumped 13% in extended trading.
Expect continued upside as investors price in accelerated AI revenue and higher guidance.
The beat, large post‑earnings price move, and raised full‑year guidance provide a clear, time‑sensitive catalyst.
Market effects
AI‑focused enterprise software sector may see broader rally on Salesforce's AI progress.
U.S. tech equities likely benefit from the positive earnings surprise.
Highlights the growing importance of generative AI in cloud and SaaS markets worldwide.
Counterpoint
Some investors may worry about valuation stretch after a 13% jump and question sustainability of AI revenue growth.
Key entities
- companySalesforce
Enterprise‑software provider reporting earnings.
- companyAnthropic
AI lab whose Claude model is being integrated into Salesforce.




